ArticleThe Journal of pathology2023

CRISPR-induced exon skipping of β-catenin reveals tumorigenic mutants driving distinct subtypes of liver cancer.

Haiwei Mou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.